How regenerative is "regenerative"? A quantitative score to benchmark therapy performance across tissues [0.03%]
“再生”意味着什么？一种量化分数，可跨组织衡量治疗效果
Franco Grimolizzi
Franco Grimolizzi
The term "regenerative" now describes an extraordinarily broad range of therapies: advanced cell and gene therapies sit alongside off-the-shelf scaffolds, injectable biologics, and topical formulations. Yet there are no agreed criteria for ...
Industry updates from the field of stem cell research and regenerative medicine in November 2025 [0.03%]
2025年11月国内外干细胞研究及再生医学领域进展
Dusko Ilic,Mirjana Liovic
Dusko Ilic
Latest developments in the field of Advanced Therapy Medicinal Products and regenerative medicine compiled from publicly available information and press releases from non-academic institutions in November 2025. ...
Industry updates from the field of stem cell research and regenerative medicine in December 2025 [0.03%]
2025年12月干细胞研究与再生医学领域行业动态更新
Dusko Ilic,Mirjana Liovic
Dusko Ilic
Latest developments in the field of Advanced Therapy Medicinal Products and regenerative medicine compiled from publicly available information and press releases from non-academic institutions in December 2025. ...
Evaluating the utility of a patient and public involvement and engagement (PPIE) end-of-trial event to re-engage with cell-based therapy participants [0.03%]
评估患者和公众参与(PPIE)期终事件的实用性以重新与细胞疗法参与者建立联系
Deepak Menon,Jan-Herman Kuiper,Andrea Bailey et al.
Deepak Menon et al.
Aims: Although research in cell-based therapy is expanding, little is known about patient experience in cell therapy trials to-date. This study explores the experience and attitudes of participants involved in the ASCOT r...
Biomaterial platforms in cardiovascular regenerative medicine - challenges and future perspectives [0.03%]
心血管再生医学中的生物材料平台-挑战与未来前景
Quan Duy Vo
Quan Duy Vo
Cardiovascular diseases (CVDs) remain the leading cause of death worldwide, responsible for about 17.9 million deaths annually. Induced pluripotent stem cells (iPSCs) offer a patient-specific and ethically acceptable source for cardiac rege...
Reimbursement routes and past practices for advanced therapy medicinal products in the Netherlands [0.03%]
荷兰先进治疗药品的报销途径及既往做法
Jurriaan Gort,Christine C van Hattem,Floris Logman et al.
Jurriaan Gort et al.
Aim: Achieving market access for advanced therapy medicinal products (ATMPs) requires navigating national reimbursement routes. This is said to be particularly challenging for academic developers and small- and medium-siz...
Three-dimensional bio-printed microtissues: precision medicine approach in primary liver cancer [0.03%]
三维生物打印微组织：原发性肝癌的精准医疗方法
Hani Keshavarz Alikhani,Homeyra Seydi,Kosar Nouri et al.
Hani Keshavarz Alikhani et al.
Despite remarkable progress in the clinical management of hepatocellular carcinoma (HCC), complications such as heterogenicity of HCC cells and characteristics of cancer stem cells (CSCs) contribute to frequent relapse and treatment resista...
Industry updates from the field of stem cell research and regenerative medicine in October 2025 [0.03%]
2025年10月干细胞研究和再生医学领域行业动态更新
Dusko Ilic,Mirjana Liovic
Dusko Ilic
Latest developments in the field of Advanced Therapy Medicinal Products and regenerative medicine compiled from publicly available information and press releases from non-academic institutions in October 2025. ...
Revolutionizing regeneration: stem cells transform treatment of hidrotic ectodermal dysplasia (Clouston syndrome) [0.03%]
再生革命：干细胞改变汗管外胚叶发育不全（克劳斯通综合征）的治疗模式
Asad Ullah,Ubaid Ur Rehman,Yasir Zeb et al.
Asad Ullah et al.
Clouston syndrome is a rare autosomal dominant form of hidrotic ectodermal dysplasia that presents significant challenges due to its multisystemic manifestations and limited therapeutic options. This review explores the functional role of s...
Industry updates from the field of stem cell research and regenerative medicine in July 2025 [0.03%]
2025年7月干细胞研究与再生医学领域行业动态更新
Dusko Ilic,Mirjana Liovic
Dusko Ilic
Latest developments in the field of Advanced Therapy Medicinal Products and regenerative medicine compiled from publicly available information and press releases from non-academic institutions in July 2025. ...